Turkish radiation oncologists typically review sarcoma cases through multidisciplinary tumor boards. Specialists from radiation oncology sit with surgeons and radiologists to plan care. This team-based approach is a standard at major JCI-accredited centers in Istanbul and Ankara. These panels optimize treatment timing and radiation dosage for complex tumors.
- Specialized board members: Boards include radiation oncologists, medical oncologists, and expert pathologists.
- Case optimization: Teams collectively evaluate imaging and pathology to determine the best surgical margins.
- Personalized radiotherapy: Specialists choose between pre-operative or post-operative radiation based on group consensus.
- Advanced technology integration: Boards coordinate the use of CyberKnife or MR Linac for precise targeting.
Bookimed Expert Insight: Many leading Turkish oncologists, such as Dr. Mustafa Solak and Dr. Banu Atalar, bring international expertise from institutions like MD Anderson and Stanford. Dr. Atalar currently serves as the President of the Turkish Society for Radiation Oncology. This level of leadership ensures that local tumor boards follow global protocols for rare sarcoma cases. Patients can access expert consultations with these specialists starting from $100.
Patient Consensus: Patients note that a single doctor deciding a plan alone is often a red flag for rare tumors. They emphasize asking if pathology was re-read by a sarcoma specialist during board reviews. Most find that receiving a written recommendation from the entire clinical team provides significant peace of mind.
